Oncology Voice Network
Join the Oncology Voice Network. Join for Free
Celebrating 100 Episodes: Top MSL Insights, Career Tips, and Community Gratitude
MSL Podcast Medical Science Liaison Career Progression Emotional Intelligence Networking Strategies

Celebrating 100 Episodes: Top MSL Insights, Career Tips, and Community Gratitude

  • Apr 19th 2022
  • 42 mins
  • E100

Share This Article

Summary

In the milestone 100th episode of MSL Talk, Tom Caravela celebrates the journey of the podcast and extends gratitude to the supportive community. Reflecting on the podcast's evolution, Tom quizzes listeners on the most downloaded episode and revisits highlights and essential MSL attributes from the early days. He delves into topics like emotional intelligence, career transitions, and field medical excellence. The episode covers crucial aspects of career progression, market saturation, and effective job search strategies. Tom emphasizes the significance of diversity, networking, and personal growth, concluding with a heartfelt expression of gratitude and a recap of key insights.

Please join me for a very special MSL Talk Podcast milestone.
This episode marks our 100th since we started back on March 27th, 2020.
In this episode, I will offer some fun facts, statistics, and behind-the-scenes information, as well as provide a recap per category.


Special thanks to ALL of my awesome guests over the past 2 years and of course, thank YOU to our listeners throughout the world.

Click for Source
MSL Podcast, Medical Science Liaison, Career Progression, Emotional Intelligence, Networking Strategies

Related Topics

Explore the Ecosystem

Meet Our Innovation Partners

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Aug 5th • 31 mins • listen
Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Jul 15th • 37 mins • listen
Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Feb 22nd • 10 mins • read
Podcast
Hiring Managers Beware: Reverse Rejection Explained!
Partner Avatar Michael Pietrack

Hiring Managers Beware: Reverse Rejection Explained!

Nov 26th • 2 mins • listen
Article
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
OVN Avatar Jamie Riley

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

Feb 4th • 7 mins • read
Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Apr 26th • 15 mins • read

Explore OVN

Articles Expert-written insights
Browse Ecosystem Oncology focus areas
OVN Podcast Flagship show
Community Why join OVN